Oxyphenbutazone-induced sialadenitis.
D000208:Acute Disease; D005260:Female; D006801:Humans; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000009:adverse effects* / Q000627:therapeutic use; D012466:Salivary Gland Diseases / Q000139:chemically induced*; D012793:Sialadenitis / Q000139:chemically induced*; D013924:Thrombophlebitis / Q000188:drug therapy; D014987:Xerostomia / Q000139:chemically induced
D010113:Oxyphenbutazone